Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 267 results for "medicines for malaria venture"

Cresset Discovery Services provides computer-aided drug design...

Cambridge, UK 11th February 2016 Cresset Discovery Services, provider of contract research services for early phase discovery, and Medicines for Malaria Venture (MMV), have entered into a collaborative agreement to use computer-aided drug ... PharmaVOICE, 6 hours ago
New malaria target identified Hospital Pharmacy Europe, 1 month ago

1 images for "medicines for malaria venture"

Cambridge Network, 2 hours ago

A Bill Gates-Backed Gene Editing Startup Is Going Public

Editas Medicine -- a startup backed by Bill Gates and Google Ventures, among others -- has filed to become the first gene-editing medical technology company to go public. The company, which filed an initial public offering with the Security and ...
 Entrepreneur.com1 month ago Editas Medicine Files IPO  Fortune1 month ago 11 Crazy Gene-Hacking Things We Can Do with CRISPR  Popular Mechanics2 weeks ago

'Smart' drug in development to tackle resistant strain of malaria

The parasite that transmits malaria has become increasingly resistant to medical treatments. Until recently, the most effective antimalarial drug was artemisinin. But, resistance to the drug has developed in Asia and doctors fear that ...
 NewsGrio1 day ago Synergistic Malaria Parasite Killing by Two Types of Plasmodial Surface Anion Channel Inhibitors  Plosone.org13 hours ago New drug in race against malaria's deadly resistance to treatment  Noodls1 day ago New wish in tellurian competition to kick malaria parasite's lethal new resistance  HealthMediciNet.com1 day ago

Rwanda: Medics on How to Consolidate Gains Made in Health Sector

Training health workers is a costly venture. Unfortunately, the demands on the health sector have more than doubled as more people seek quality health care. The world continues to grapple with emerging health needs, with the African continent ...
 AllAfrica.com2 weeks ago

Nigeria: Drug Maker Supplied 300 Million Child-Friendly Anti-Malarial Medicines Without Profit(Independent (Lagos))

Multi-national drug firm, Novartis, has said it delivered 300 million pediatric anti-malarial treatments supplied without profit since 2009, helping to reduce the disease burden for children in more than 30 malaria-endemic countries. This, ...
 AllAfrica.com2 months ago Drug Maker Supplied 300 million Child-Friendly Anti-malarial Medicines Without Profit  Nigeria Daily Independent2 months ago 300 Million Child-Friendly Antimalarial Treatments Supplied without Profit by Novartis  Pharmacy Times1 month ago Novartis Marks Delivery of 300 Million Free, Child-Friendly Antimalarial Treatments  American Pharmaceutical Review1 month ago

Obama's Upbeat Message About Ending Malaria Omits Discouraging Signs

Yonta, 6, rests with her sister Montra, 3, and brother Leakhena, 4 months, under a mosquito bed net during monsoon season in July 2010, in Pailin province, Cambodia. Paula Bronstein/ hide caption toggle caption Paula Bronstein/ President ...
 NPR3 weeks ago

2015 Nobel Laureates in Physiology or Medicine [Profiles]

Wesley C. Van Voorhis a , b , c , 1 , Rob Hooft van Huijsduijnen d , and Timothy N. C. Wells d a Center for Emerging and Re-emerging Infectious Diseases, Division of Allergy and Infectious Diseases, Department of Medicine, University of ...
 PNAS1 month ago

Coming of the Light: The 2015 Integrator Top 10 for Policy and Action in Integrative Health and Medicine

The Integrator Blog News & Reports annually marks the winter solstice with a Top 10 list in integrative health and medicine. The focus is on positive signs -- the coming of the light -- in policy and action from individuals and organizations in the ...
 Huffington Post1 month ago

ViiV secures patents for key HIV drugs dolutegravir and cabotegravir opposed in India

People living with HIV have opposed patent applications in India for two important HIV medicines, dolutegravir and cabotegravir. Médecins Sans Frontières/ Doctors Without Borders (MSF) supports these patent oppositions, which have been filed to ...
 India Infoline1 day ago Pharma Company Attempt to Secure Patents for Key HIV Drugs Opposed in India  MSF-USA1 day ago

Elastagen Completes A$13m Series B Equity Financing

SYDNEY, Jan. 7, 2016 /PRNewswire/ -- Elastagen Pty Ltd, a clinical stage medical company developing products based on a proprietary recombinant human tropoelastin platform technology, announces the closing of a A$13 million Series B financing round.
 Fierce Drug Delivery1 month ago Elastagen Pty Limited Completes A $13 Million Series B Equity Financing  BioSpace1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - medicines for malaria venture
Get updated on latest news & your favorite topics right in your inbox!
More     Less